why choose us

First received: August 01, 2024

Clinical Trial: Sarcopenic Index and Related Factors in Patients With Type 2 Diabetes

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Type 2 Diabetes

Study Type: OBSERVATIONAL


Official Title: Sarcopenic Index and Related Factors in Patients With Type 2 Diabetes Applying to Tertiary Health Care Services

Brief Summary: Sarcopenia, characterized by a progressive loss of skeletal muscle mass and function, is particularly common in individuals with T2DM and is often associated with insulin resistance, chronic inflammation and oxidative stress.The Sarcopenia Index (SI), calculated as serum creatinine divided by serum cystatin C, is a practical tool for assessing sarcopenia and is used in many clinical settings.In this study, we aimed to investigate the relationship between sarcopenic index and variables such as age, diabetes…

Read more